{rfName}
Ch

Indexed in

License and use

Altmetrics

Analysis of institutional authors

Barreiro PAuthorAntolin Alvarado EAuthorDe La Calle MAuthorArribas JrAuthorBartha JlAuthor

Share

March 2, 2020
Publications
>
Article
No

Characteristics of Zika virus infection among international travelers: A prospective study from a Spanish referral unit

Publicated to:Travel Medicine and Infectious Disease. 33 (101543): 101543- - 2020-01-01 33(101543), DOI: 10.1016/j.tmaid.2019.101543

Authors: Crespillo-Andujar, Clara; Diaz-Menendez, Marta; Trigo, Elena; Arsuaga, Marta; De la Calle, Fernando; Lago, Mar; Ladron de Guevara, Maria Concepcion; Barreiro, Pablo; Montero, Dolores; Garcia-Bujalance, Silvia; Antolin Alvarado, Eugenia; de la Calle, Maria; Paz Sanchez-Seco, Maria; de Ory, Fernando; Vazquez, Ana; Arribas, Jose R; Garcia, Julio; Martin-Boado, Elena; Martinez-Sanchez, Nuria; Rodriguez, Roberto; Herrero, Beatriz; Lopez, Francisco; Luis Bartha, Jose; Dolores Elorza, Maria; Cabrera Lafuente, Marta; Garcia Hortelano, Milagros

Affiliations

Dept Gynecol & Obstet, Madrid, Spain - Author
Dept Gynecol & Obstet, Ultrasound & Fetal Med Sect, Madrid, Spain - Author
Hosp Univ La Paz Carlos III, Dept Gynecol & Obstet, IdiPAZ, Madrid, Spain - Author
Hosp Univ La Paz Carlos III, IdiPAZ, Natl Referral Unit Trop & Travel Med, Dept Internal Med, Madrid, Spain - Author
Hosp Univ La Paz Carlos III, Microbiol & Parasitol, IdiPAZ, Madrid, Spain - Author
Hosp Univ La Paz Carlos III, Microbiol, IdiPAZ, Madrid, Spain - Author
IdiPAZ, C Sinesio Delgado 10, Madrid 28029, Spain - Author
Inst Hlth Carlos III, Biomed Res Networking Ctr Publ Hlth CiberESP, Natl Microbiol Ctr, Madrid, Spain - Author
Inst Hlth Carlos III, Natl Microbiol Ctr, Madrid, Spain - Author
Inst Invest Hosp La Paz IdiPaz, Dept Internal Med, Infect Dis Unit, Madrid, Spain - Author
Instituto de Investigacion Hospital Universitario La Paz (IdiPAZ) - Author
National Microbiology Centre - Author
National Referral Unit for Tropical and Travel Medicine - Author
Neonatology Unit - Author
Pediat Dept, Natl Referral Unit Trop & Travel Med, Madrid, Spain - Author
Pediat Dept, Neonatol Unit, Madrid, Spain - Author
Ultrasound and Fetal Medicine Section - Author
See more

Abstract

© 2019 Elsevier Ltd Background: From the first Zika virus (ZIKV) description, it has progressively widespread worldwide. We analyzed demographic, clinical, microbiologic and travel-related characteristic from returned patients from a ZIKV endemic country in a referral Tropical Medicine Unit. Method: A prospective cohort study performed in a Spanish referral center with the aim of determining the significant factors associated with confirmed Zika virus (ZIKV) infection. Results: 817 patients, (56% women, median age 36 [IQR, Interquartile Range: 32–42]) were enrolled. Most had returned from Latin America (n = 486; 59.4%), travelled for tourism (n = 404; 49.4%) and stayed a median of 18 days (IQR: 10–30). 602 (73.6%) presented symptoms, but only 25 (4%) were finally diagnosed with confirmed ZIKV infection (including two pregnant women, without adverse fetal outcomes), 88% (n:22) presented with fever and 92% (n:23) with rash. 56% (n:14) arthralgia and/or myalgia and 28% (n:7) conjunctivitis. The presence of conjunctivitis, fever and rash were associated with an 8.9 (95% CI: 2.2–34.9), 6.4 (95% CI: 1.2–33.3) and 72.3 (95% CI: 9.2–563.5) times greater probability of confirmed ZIKV infection, respectively. Conclusion: Travel characteristics and clinical presentation may help clinicians to optimize requests for microbiological testing. Diagnosis of arboviriasis in travellers arriving form endemic areas remains a challenge for clinicians, but must be detected for the possible transmission outside endemic areas, where the vector is present.

Keywords

arbovirus infectionsendemic diseasetravel medicineArbovirus infectionsEndemic diseaseTravel medicineZika virus

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Travel Medicine and Infectious Disease due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2020, it was in position 9/92, thus managing to position itself as a Q1 (Primer Cuartil), in the category Infectious Diseases. Notably, the journal is positioned above the 90th percentile.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2025-08-09:

  • WoS: 3
  • Scopus: 5

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-09:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 81.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 81 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 1.25.
  • The number of mentions on the social network X (formerly Twitter): 4 (Altmetric).